About Us
About Noxopharm
CEO's Message
Management Team
Board of Directors
Scientific Advisors
Our Network
Pharmorage
ESG Commitment
Technology
Technology Platforms
Sofra™
RNA Vaccines and Therapeutics
Autoimmune Disease
Scientific Background
Chroma™
Clinical Trials
Publications & Events
Investor Centre
Share Price
ASX Announcements
Presentations, Interviews & Media
Annual Reports
Financial Reports
Corporate Governance
Investor Fact Sheet
Share Registry Information
Contact Us
Contact Us
Partnering
Working at Noxopharm
ASX Announcements Email Alerts
Investor Centre
Investor Centre
>
Financial Reports
Share Price
ASX Announcements
Presentations, Interviews & Media
Annual Reports
Financial Reports
Corporate Governance
Investor Fact Sheet
Share Registry Information
Financial Reports
Filter by Year:
2026
2025
2024
2023
2022
2021
2020
2019
Older
30-Oct-2017
Appendix 4C – Quarterly report for the quarter ended September 30, 2017
31-Aug-2017
Appendix 4E and Audited Financial Statements
31-Jul-2017
Appendix 4C – Quarterly report for the quarter ended June 30, 2017
27-Apr-2017
Appendix 4C – Quarterly report for the quarter ended 31 March 2017
3-Apr-2017
Appendix 3B
24-Feb-2017
Appendix 4D and Half Year Accounts
30-Jan-2017
Appendix 4C – Quarterly report for the quarter ended 31 December 2016
9-Jan-2017
Appendix 3B
1
